קסטרל 5 מג SR
Country: Ísrael
Tungumál: hebreska
Heimild: Ministry of Health
Upplýsingar fylgiseðill
(PIL)
12-10-2022
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
ALFUZOSIN HYDROCHLORIDE
Fáanlegur frá:
SANOFI ISRAEL LTD
ATC númer:
G04CA01
Lyfjaform:
טבליות עם שחרור מושהה
Samsetning:
ALFUZOSIN HYDROCHLORIDE 5 MG
Stjórnsýsluleið:
פומי
Gerð lyfseðils:
מרשם נדרש
Framleitt af:
SANOFI WINTHROP INDUSTRIE, FRANCE
Meðferðarhópur:
ALFUZOSIN
Lækningarsvæði:
ALFUZOSIN
Ábendingar:
Treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason
Vörulýsing:
1. התרופה תינתן לטיפול בהגדלה שפירה של בלוטת הערמונית. 2. התרופה תינתן על פי מרשם של רופא מומחה באורולוגיה.
Leyfisdagur:
2023-03-31
Upplýsingar fylgiseðill
1986±ʥʮʹʺʤ ʭʩʸʩʹʫʺ ʭʩʧʷʥʸʤʺʥʰʷʺʩʴʬʯʫʸʶʬʯʥʬʲ
ʣʡʬʡʠʴʥʸʭʹʸʮʩʴʬʲʺʷʥʥʹʮʤʴʥʸʺʤ
ʢʮ5 SR ʬʸʨʱʷ
ʤʤʹʥʮʸʥʸʧʹʬ ʺʥʩʬʡʨ
ʢʮ5 HCIʯʩʱʥʦʥʴʬʠ ʤʬʩʫʮʢʮ5 SR
ʬʸʨʱʷʺʩʩʬʡʨʬʫ
.alfuzosin HCI 5 mg
ʳʱʥʰʲʣʩʮ6
ʷʸʴʤʠʸ ʭʩʩʰʢʸʬʠʥʭʩʬʩʲʴʩʺʬʡʭʩʸʮʥʧ
ʤʴʥʸʺʡʹʮʺʹʺʭʸʨʡʥʴʥʱʣʲʯʥʬʲʤʺʠʯʥʩʲʡʠʸʷ
ʬʠʤʰʴʺʥʴʱʥʰʺʥʬʠʹʪʬʹʩʭʠʤʴʥʸʺʤʬʲʩʺʩʶʮʺʲʣʩʮʬʩʫʮʤʦʯʥʬʲ
ʧʷʥʸʤʬʠʥʠʠʴʥʸʤ
ʭʤʬʷʩʦʤʬʤʬʥʬʲʠʩʤʭʩʸʧʠʬʤʺʥʠʸʩʡʲʺʬʠʪʸʥʡʲʤʮʹʸʰʥʦʤʴʥʸʺ
ʭʩʸʡʢʬʺʣʲʥʩʮʤʴʥʸʺʤʤʮʥʣʩʠʥʴʸʤʭʡʶʮʩʫʪʬʤʠʸʰʭʠʥʬʩʴʠ
ʭʩʰʹ16ʬʩʢʬʺʧʺʮʭʩʸʢʡʺʮʥʭʩʣʬʩʡʬʥʴʩʨʬʺʣʲʥʩʮʤʰʩʠʥʦʤʴʥʸʺ
1 .
"ʤʴʥʸʺʤʺʣʲʥʩʮʤʮʬ
ʬʹ ʤʸʩʴʹ ʤʬʣʢʤʬ ʭʩʸʥʹʷʤ ʭʩʰʩʮʱʺʡ
ʬʥʴʩʨʬ ʺʹʮʹʮ SR ʬʸʨʱʷ
ʧʥʺʩʰʤʲʥʶʩʡʡʡʥʫʩʲʥʰʹʩʭʠʨʸʴʡ ʤʨʨʱʥʸʴ ʺʩʰʥʮʸʲʤ
ʺʩʨʩʥʴʸʺʤʶʥʡʷ
ʩʡʩʨʷʬʱʭʱʥʧʤʰʩʤʥʠʴʬʠʩʮʱʥʧʭʩʠʸʷʰʤʭʩʸʩʹʫʺʺʶʥʡʷʬʺʫʩʩʹʬʸʨʱʷ
ʺʧʠʠʴʬʠ Į1ʸʥʨʴʶʸʤʬʹ
2 .
ʤʴʥʸʺʡʹʥʮʩʹʤʩʰʴʬ
:ʤʴʥʸʺʡʹʮʺʹʤʬʯʩʠ
x
ʷʸʴʤʠʸ ʤʴʥʸʺʤʩʡʩʫʸʮʮʣʧʠʬʥʠʯʩʱʥʦʥʴʬʠʬ ʩʢʸʬʠ ʹʩʢʸʪʰʩʤʭʠ
.(6
x
Orthostatic ʩʨʨʱʥʺʸʥʠ ʭʣ ʵʧʬʮ ʸʡʲʡ ʺʬʡʱ
ʥʠ ʬʡʥʱ ʪʰʩʤ ʭʠ
ʭʷʤʺʠʸʹʠʫʺʹʧʸʺʮʤʭʣʤʵʧʬʡʺʩʮʥʠʺʴʤʣʩʸʩ hypotension
ʤʡʩʫʹʮʥʠʤʡʩʹʩʮʺʥʩʮʥʠʺʴʡ
x
ʭʩʸʧʠĮʩʮʱʥʧʭʲʡʥʬʩʹʡ
x
ʣʡʫʤʣʥʷʴʺʡʤʣʩʸʩʮʬʡʥʱʪʰʩʤʭʠ
ʤʴʥʸʺʡʹʥʮʩʹʬʺʥʲʢʥʰʤʺʥʣʧʥʩʮʺʥʸʤʦʠ
ʠʴʥʸ
Lestu allt skjalið
